The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
Open accessAbstract
Purpose: Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance of individual chromosomal abnormalities in this age group remains unclear. Patients and Methods: This cytogenetic study of 729 childhood patients classified them into 22 subgroups and evaluated their incidence and risk. Results: Rearrangements of 11q23 were the most frequent abnormality found in approximately 16% of patients, with 50% of these in infants. The outcome for all patients with 11q23 abnormalities was intermediate; no difference was observed for those with t(9;11)(p21-22;q23). The core binding factor leukemias with the translocations t(8;21)(q22;q22) and inv(16)(p13q22) occurred at incidences of 14% and 7%, respectively, predominantly in older children, and their prognosis was favorable. An adverse outcome was observed in patients with monosomy 7, abnormalities of 5q, and t(6;9)(p23;q34). Abnormalities of 3q and complex karyotypes, in the absence of favorable-risk features, have been associated with an adverse outcome in adults, but the results were not significant in this childhood series. However, the presence of 12p abnormalities predicted a poor outcome. Conclusion: Because the spectrum of chromosomal changes and their risk association seem to differ between children and adults with AML, biologic differences are emerging, which will contribute to the redefinition of risk stratification for different age groups in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International System for Human Cytogenetic Nomenclature
National Cancer Institute (2020) · Definitions · doi:10.32388/78qroa · Cited by 6,840
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D., Larson, R. A., et al. (2010) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,373
Self-citationWHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
Self-citationISCN 1995 An international system for human cytogenetic nomenclature
Mitelman, F. (1995) · Cited by 1,930
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Byrd, J. C. (2002) · Blood · doi:10.1182/blood-2002-03-0772 · Cited by 1,597
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Gale, R. E., Green, C., Allen, C., Mead, A. J., Burnett, A. K., Hills, R. K., & Linch, D. C. (2008) · Blood · doi:10.1182/blood-2007-08-109090 · Cited by 745
Self-citationFusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S. (1993) · Science · doi:10.1126/science.8351518 · Cited by 732
Erickson, P., Gao, J., Chang, K., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J., & Drabkin, H. (1992) · Blood · doi:10.1182/blood.v80.7.1825.1825 · Cited by 631
Ziemin-van der Poel, S., McCabe, N. R., Gill, H. J., Espinosa, R., Patel, Y., Harden, A., Rubinelli, P., Smith, S. D., LeBeau, M. M., & Rowley, J. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10735 · Cited by 585
Mrózek, K., Marcucci, G., Paschka, P., Whitman, S. P., & Bloomfield, C. D. (2007) · Blood · doi:10.1182/blood-2006-06-001149 · Cited by 552
Meshinchi, S., Woods, W. G., Stirewalt, D. L., Sweetser, D. A., Buckley, J. D., Tjoa, T. K., Bernstein, I. D., & Radich, J. P. (2001) · Blood · doi:10.1182/blood.v97.1.89 · Cited by 518
Balgobind, B. V., Raimondi, S. C., Harbott, J., Zimmermann, M., Alonzo, T. A., Auvrignon, A., Beverloo, H. B., Chang, M., Creutzig, U., Dworzak, M. N., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215152 · Cited by 445
Self-citationBarjesteh van Waalwijk van Doorn-Khosrovani, S. (2003) · Blood · doi:10.1182/blood-2002-05-1459 · Cited by 355
Schoch, C., Schnittger, S., Klaus, M., Kern, W., Hiddemann, W., & Haferlach, T. (2003) · Blood · doi:10.1182/blood-2003-02-0434 · Cited by 352
Raimondi, S. C., Chang, M. N., Ravindranath, Y., Behm, F. G., Gresik, M. V., Steuber, C. P., Weinstein, H. J., & Carroll, A. J. (1999) · PubMed · doi:10.1182/blood.v94.11.3707 · Cited by 323
Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
Gibson, B. E. S., Wheatley, K., Hann, I. M., Stevens, R. F., Webb, D., Hills, R. K., De Graaf, S. S. N., Harrison, C. J., & for the United Kingdom Childhood Leukaemia Working Party, A. T. D. C. O. G. (2005) · Leukemia · doi:10.1038/sj.leu.2403924 · Cited by 303
Self-citationHann, I. M., Stevens, R. F., Goldstone, A. H., Rees, J. K. H., Wheatley, K., Gray, R. G., & Burnett, A. K. (1997) · Blood · doi:10.1182/blood.v89.7.2311 · Cited by 297
Self-citationTransplacental chemical exposure and risk of infant leukemia with MLL gene fusion.
Alexander, F. E., Patheal, S. L., Biondi, A., Brandalise, S. R., Cabrera, M. E., Chan, L., Chen, Z., Cimino, G. G., Córdoba, J. C., Gu, L. J., et al. (2001) · PubMed · Cited by 297
Haferlach, C., Dicker, F., Herholz, H., Schnittger, S., Kern, W., & Haferlach, T. (2008) · Leukemia · doi:10.1038/leu.2008.143 · Cited by 247
Favorable Impact of the t(9;11) in Childhood Acute Myeloid Leukemia
Rubnitz, J. E., Raimondi, S. C., Tong, X., Srivastava, D. K., Razzouk, B. I., Shurtleff, S. A., Downing, J. R., Pui, C.-H., Ribeiro, R. C., & Behm, F. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.023 · Cited by 225
The incidence and clinical significance of nucleophosmin mutations in childhood AML
Brown, P., McIntyre, E., Rau, R., Meshinchi, S., Lacayo, N., Dahl, G., Alonzo, T. A., Chang, M., Arceci, R. J., & Small, D. (2007) · Blood · doi:10.1182/blood-2007-02-076604 · Cited by 216
Ho, P. A., Alonzo, T. A., Gerbing, R. B., Pollard, J., Stirewalt, D. L., Hurwitz, C., Heerema, N. A., Hirsch, B., Raimondi, S. C., Lange, B., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184747 · Cited by 215
Schoch, C., Kern, W., Kohlmann, A., Hiddemann, W., Schnittger, S., & Haferlach, T. (2005) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20193 · Cited by 188
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype
Cazzaniga, G., Dell'Oro, M. G., Mecucci, C., Giarin, E., Masetti, R., Rossi, V., Locatelli, F., Martelli, M. F., Basso, G., Pession, A., et al. (2005) · Blood · doi:10.1182/blood-2005-03-0899 · Cited by 178
Dastugue, N. (2002) · Blood · doi:10.1182/blood-2001-12-0241 · Cited by 163
Hasle, H., Alonzo, T. A., Auvrignon, A., Béhar, C., Chang, M. N., Creutzig, U., Fischer, A., Forestier, E., Fynn, A. B., Haas, O. A., et al. (2007) · Blood · doi:10.1182/blood-2006-10-051342 · Cited by 154
Self-citationChessells, J. M., Harrison, C. J., Kempski, H. M., Webb, D. K. H., Wheatley, K., Hann, I. M., Stevens, R., Harrison, G., & Gibson, B. E. S. (2002) · Leukemia · doi:10.1038/sj.leu.2402468 · Cited by 113
Self-citationBaldus, C. D., Mrózek, K., Marcucci, G., & Bloomfield, C. D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06566.x · Cited by 102
van der Holt, B., Breems, D. A., Beverloo, H. B., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06403.x · Cited by 69
t(7;12)(q36;p13), a new recurrent translocation involvingETV6 in infant leukemia
Tosi, S., Harbott, J., Teigler‐Schlegel, A., Haas, O. A., Pirc‐Danoewinata, H., Harrison, C. J., Biondi, A., Cazzaniga, G., Kempski, H. M., Scherer, S. W., et al. (2000) · Genes Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1039>3.0.co;2-9 · Cited by 68
Self-citationPopulation-based demographic study of karyotypes in 1709 patients with adult Acute Myeloid Leukemia
Sanderson, R., Johnson, P. R. E., Moorman, A. V., Roman, E., Willett, E. V., Taylor, P. R. A., Proctor, S. J., Bown, N. P., Ogston, S., & Bowen, D. (2006) · Leukemia · doi:10.1038/sj.leu.2404055 · Cited by 59
Self-citationSecker‐Walker, L. M., Morgan, G. J., Min, T., Swansbury, G. J., Craig, J. M., Yamada, T., Desalvo, L., Medina, J. W., Chowdhury, V., Donahue, R. P., et al. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90129-v · Cited by 44
Cited by
Grimwade, D., Hills, R. K., Moorman, A. V., Walker, H., Chatters, S., Goldstone, A. H., Wheatley, K., Harrison, C. J., Burnett, A. K., & on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) · Blood · doi:10.1182/blood-2009-11-254441 · Cited by 1,938
Self-citationCreutzig, U., van den Heuvel-Eibrink, M. M., Gibson, B., Dworzak, M. N., Adachi, S., de Bont, E., Harbott, J., Hasle, H., Johnston, D., Kinoshita, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-362608 · Cited by 577
Self-citationCollaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
Zwaan, C. M., Kolb, E. A., Reinhardt, D., Abrahamsson, J., Adachi, S., Aplenc, R., De Bont, E. S. J. M., De Moerloose, B., Dworzak, M., Gibson, B. E. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.8289 · Cited by 383
Self-citationMizukawa, B., Wei, J., Shrestha, M., Wunderlich, M., Chou, F.-S., Griesinger, A., Harris, C. E., Kumar, A. R., Zheng, Y., Williams, D. A., et al. (2011) · Blood · doi:10.1182/blood-2011-04-351817 · Cited by 70
Metadata
- Authors
- Harrison, C. J., Hills, R. K., Moorman, A. V., Grimwade, D. J., Hann, I., Webb, D. K. H., Wheatley, K., de Graaf, S. S. N., van den Berg, E., Burnett, A. K., & Gibson, B. E. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-06-01
- Volume
- 28
- Issue
- 16
- Pages
- 2674-2681
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2144341550
- Cited by
- 302
- References
- 36
- FWCI
- 14.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.